磁共振成像和DAT显像在帕金森病的研究进展
Research Progress of Magnetic Resonance Imaging and DAT Imaging in Parkinson’s Disease
DOI: 10.12677/ACM.2022.12121721, PDF,    科研立项经费支持
作者: 海俊杰：内蒙古医科大学研究生院，内蒙古 呼和浩特；江名芳*：内蒙古医科大学附属医院，内蒙古 呼和浩特
关键词: 帕金森病；磁共振成像；PET；多巴胺转运蛋白；Parkinson’s Disease； Magnetic Resonance Imaging； PET； Dopamine Transporter
摘要: 帕金森病是常见的神经退行性疾病，表现为静止性震颤、运动迟缓、肌强直、姿势平衡障碍、嗅觉功能障碍、睡眠障碍、自主神经功能障碍、精神障碍、认知障碍、疼痛和疲劳等临床症状。在疾病的早期与其他神经退行性有许多类似的临床症状，使帕金森病的早期诊断相对困难。影像学及核医学的发展，通过量化体内代谢物成分、探测组织微观结构、检测敏感性指标等影像学检查及显示分子在机体内分布情况的核医学显像技术，提高了帕金森病的早期诊断。文中重点阐述了质子磁共振波谱、磁共振弥散张量成像、磁敏感加权成像及多巴胺转运蛋白正电子发射断层扫描显像在诊断早期帕金森病中的研究进展。
Abstract: Parkinson’s disease is a common neurodegenerative disease. it is characterized by clinical symp-toms such as resting tremor, motor retardation, myotonia, postural balance disorder, olfactory dysfunction, sleep disorder, autonomic nervous dysfunction, mental disorder, cognitive impairment, pain and fatigue. There are many clinical symptoms similar to other neurodegenerative diseases in the early stage of the disease, which makes the early diagnosis of Parkinson’s disease relatively difficult. With the development of imaging and nuclear medicine, the early diagnosis of Parkinson’s disease has been improved by quantifying the composition of metabolites, detecting tissue microstructure, detecting sensitivity indexes and nuclear medical imaging technology to show the distribution of molecules in the body. This paper focuses on the research progress of proton magnetic resonance spectroscopy, magnetic resonance diffusion tensor imaging, magnetic sensitivity weighted imaging and dopamine transporter positron emission tomography in the di-agnosis of early Parkinson’s disease.
文章引用：海俊杰, 江名芳. 磁共振成像和DAT显像在帕金森病的研究进展[J]. 临床医学进展, 2022, 12(12): 11946-11953. https://doi.org/10.12677/ACM.2022.12121721

参考文献

[1] Abbas, M.M., Xu, Z. and Tan, L. (2018) Epidemiology of Parkinson’s Disease—East versus West. Movement Disor-ders Clinical Practice, 5, 14-28. [Google Scholar] [CrossRef] [PubMed]
[2] Shnayder, N.A., Sapronova, M.R., Petrova, M.M., et al. (2017) The Role of High Field Magnetic Resonance Imaging of the Brain in the Diagnosis of Early-Stage Parkinson’s Disease: A Clinical Case. Klinicist.
[3] Masato, A., Plotegher, N., Boassa, D., et al. (2019) Impaired Dopamine Metabolism in Parkinson’s Disease Pathogenesis. Molecular Neurodegeneration, 14, 35. [Google Scholar] [CrossRef] [PubMed]
[4] McLean, M.A. and Cross, J.J. (2009) Magnetic Resonance Spectroscopy: Principles and Applications in Neurosurgery. British Journal of Neurosurgery, 23, 5-13. [Google Scholar] [CrossRef] [PubMed]
[5] Massana, G., Gasto, C., Junque, C., et al. (2002) Reduced Lev-els of Creatine in the Right Medial Temporal Lobe Region of Panic Disorder Patients Detected with 1H Magnetic Res-onance Spectroscopy. Neuroimage, 16, 836-842. [Google Scholar] [CrossRef] [PubMed]
[6] Galban, C.J. and Spencer, R.G. (2002) Optimized Pulse Parameters for Reducing Quantitation Errors Due to Saturation Factor Changes in Magnetic Resonance Spectroscopy. Journal of Magnetic Resonance, 156, 161-170. [Google Scholar] [CrossRef] [PubMed]
[7] Soares, D.P. and Law, M. (2009) Magnetic Resonance Spectroscopy of the Brain: Review of Metabolites and Clinical Application. Clinical Radiology, 64, 12-21. [Google Scholar] [CrossRef] [PubMed]
[8] Nie, K., Zhang, Y., Huang, B., et al. (2013) Marked N-Acetylaspartate and Choline Metabolite Changes in Parkinson’s Disease Patients with Mild Cognitive Impairment. Parkinsonism & Related Disorders, 19, 329-334. [Google Scholar] [CrossRef] [PubMed]
[9] Levin, B.E., Katzen, H.L., Maudsley, A., et al. (2012) Whole-Brain Proton MR Spectroscopic Imaging in Parkinson’s Disease. Journal of Neuroimaging, 24, 39-44. [Google Scholar] [CrossRef] [PubMed]
[10] Guan, J., Rong, Y., Wen, Y., et al. (2017) Detection and Application of Neurochemical Profile by Multiple Regional 1H-MRS in Parkinson’s Disease. Brain and Behavior, 7, e792. [Google Scholar] [CrossRef] [PubMed]
[11] Zhou, B., Yuan, F., He, Z., et al. (2014) Application of Proton Mag-netic Resonance Spectroscopy on Substantia Nigra Metabolites in Parkinson’s Disease. Brain Imaging & Behavior, 8, 97-101. [Google Scholar] [CrossRef] [PubMed]
[12] Seraji-Bozorgzad, N., Bao, F., George, E., et al. (2015) Longitudinal Study of the Substantia Nigra in Parkinson Disease: A High-Field 1H-MR Spectroscopy Imaging Study. Movement Disorders: Official Journal of the Movement Disorder Society, 30, 1400-1404. [Google Scholar] [CrossRef] [PubMed]
[13] Lewis, S.J.G., Shine, J.M., Duffy, S., et al. (2012) Anterior Cingulate In-tegrity: Executive and Neuropsychiatric Features in Parkinson’s Disease. Movement Disorders, 27, 1262-1267. [Google Scholar] [CrossRef] [PubMed]
[14] 李俊晨, 金芳, 耿悦, 陈菊萍. 氢质子磁共振波谱成像在帕金森病早期诊断中的应用研究[J]. 交通医学, 2020, 34(4): 416-419.
[15] 郑泽熙, 马国林, 邓明秀. 磁共振波谱在帕金森病早期诊断中的应用价值[J]. 医学理论与实践, 2021, 34(23): 4147-4149.
[16] 付蓉, 李德炯, 赵晶, 等. 磁共振波谱分析在帕金森病诊断中的临床应用[J]. 第三军医大学学报, 2014, 36(19): 2055-2056.
[17] Watanabe, H., Fukatsu, H., Katsuno, M., et al. (2004) Multiple Regional 1H-MR Spectroscopy in Multiple System Atrophy: NAA/Cr Reduction in Pontine Base as a Valuable Diagnostic Marker. Journal of Neurology Neurosurgery & Psychiatry, 75, 103-109.
[18] Esterhammer, R., Schocke, M. and Seppi, K. (2010) Basal Ganglia Cellular Pathology in Multiple System Atrophy, Progressive Supranuclear Palsy and Parkinson Disease. Can Quantitative Magnetic Resonance Spectroscopic Imaging Make the Difference? European Journal of Neurology, 17, 1111-1112. [Google Scholar] [CrossRef] [PubMed]
[19] 吴武林, 王小宜, 娄明武, 等. 1H-MRS在鉴别多系统萎缩与帕金森病中的价值[J]. 中国医学影像技术, 2011, 27(2): 273-276.
[20] Zanigni, S., et al. (2015) The Contri-bution of Cerebellar Proton Magnetic Resonance Spectroscopy in the Differential Diagnosis among Parkinsonian Syn-dromes. Parkinsonism & Related Disorders, 21, 929-937. [Google Scholar] [CrossRef] [PubMed]
[21] Nicoletti, G., Lodi, R., Condino, F., et al. (2006) Apparent Diffusion Coefficient Measurements of the Middle Cerebellar Peduncle Differentiate the Parkinson Variant of MSA from Parkinson’s Disease and Progressive Supranuclear Palsy. Brain, 129, 2679-2687. [Google Scholar] [CrossRef] [PubMed]
[22] Norris, C.D., Quick, S.E., Parker, J.G., et al. (2020) Diffusion MR Im-aging in the Head and Neck: Principles and Applications. Neuroimaging Clinics of North America, 30, 261-282. [Google Scholar] [CrossRef] [PubMed]
[23] 刘莉莉, 陈艳芳. DTI在帕金森患者诊断中的应用[J]. 中国CT和MRI杂志, 2018, 16(6): 50-52.
[24] 吴佳芮. 磁共振弥散张量成像检查在帕金森病诊断中的价值[J]. 中国民康医学, 2020, 32(12): 103-105.
[25] 郭龙军, 梁长华. 磁共振弥散张量成像在帕金森病诊断与定量分析中的应用价值[J]. 中风与神经疾病杂志, 2020, 37(10): 900-903.
[26] Krismer, F., Beliveau, V., Seppi, K., et al. (2021) Auto-mated Analysis of Diffusion-Weighted Magnetic Resonance Imaging for the Differential Diagnosis of Multiple System Atrophy from Parkinson’s Disease. Movement Disorders, 36, 241-245. [Google Scholar] [CrossRef] [PubMed]
[27] Cnyrim, C.D., Kupsch, A., Ebersbach, G., et al. (2014) Diffusion Tensor Imaging in Idiopathic Parkinson’s Disease and Multisystem Atrophy (Parkinsonian Type). Neurodegenerative Diseases, 13, 1-8. [Google Scholar] [CrossRef] [PubMed]
[28] Zhang, Y., Wu, I.W., Buckley, S., et al. (2015) Diffusion Tensor Imaging of the Nigrostriatal Fibers in Parkinson’s Disease. Movement Disorders, 30, 1229-1236. [Google Scholar] [CrossRef] [PubMed]
[29] 吕德勇, 李静波, 张允, 等. 磁敏感加权成像与磁共振弥散张量成像对帕金森综合征的诊断价值[J]. 实用医院临床杂志, 2019, 16(6): 79-81.
[30] 李珊, 马莎, 王波, 等. 弥散张量成像在血管性帕金森综合征及帕金森病鉴别诊断中的应用[J]. 中国老年学杂志, 2021, 41(22): 4993-4996.
[31] Halefoglu, A.M. and Yousem, D.M. (2018) Susceptibility Weighted Imaging: Clinical Applications and Future Directions. World Journal of Radiology, 10, 30-45. [Google Scholar] [CrossRef] [PubMed]
[32] Liu, C., Li, W., Tong, K.A., et al. (2015) Susceptibility-Weighted Imaging and Quantitative Susceptibility Mapping in the Brain. Journal of Magnetic Resonance Imaging, 42, 23-41. [Google Scholar] [CrossRef] [PubMed]
[33] Schwarz, S.T., Afzal, M., Morgan, P.S., et al. (2014) The “Swallow Tail” Appearance of the Healthy Nigrosome—A New Accurate Test of Parkinson’s Disease: A Case-Control and Retrospective Cross-Sectional MRI Study at 3T. PLOS ONE, 9, e93814. [Google Scholar] [CrossRef] [PubMed]
[34] Blazejewska, A.I., Schwarz, S.T., Pitiot, A., et al. (2013) Visualization of Nigrosome 1 and Its Loss in PD: Pathoanatomical Correlation and in Vivo 7T MRI. Neurology, 81, 534-540. [Google Scholar] [CrossRef] 
[35] Reiter, E., Mueller, C., Pinter, B., et al. (2015) Dorsolateral Nigral Hyperintensity on 3.0T Susceptibility-Weighted Imaging in Neurodegenerative Parkinsonism. Movement Disorders, 30, 1068-1076. [Google Scholar] [CrossRef] [PubMed]
[36] 马松华, 邹丽, 王小乐, 等. 磁敏感加权成像对帕金森病患者的诊断价值[J]. 中国临床医学, 2018, 25(1): 87-89.
[37] Wu, S.F., Zhu, Z.F., Kong, Y., et al. (2014) Assessment of Cerebral Iron Content in Patients with Parkinson’s Disease by the Susceptibility-Weighted MRI. European Review for Medical and Pharmacological Sciences, 18, 2605-2608.
[38] Gupta, D., Saini, J., Kesavadas, C., et al. (2010) Utility of Susceptibility-Weighted MRI in Differentiating Parkinson’s Disease and Atypical Parkinsonism. Neuroradiology, 52, 1087-1094. [Google Scholar] [CrossRef] [PubMed]
[39] Pang, H., Yu, Z., Li, R., et al. (2020) MRI-Based Radiomics of Basal Nuclei in Differentiating Idiopathic Parkinson’s Disease from Parkinsonian Variants of Multiple System Atrophy: A Susceptibility-Weighted Imaging Study. Frontiers in Aging Neuroscience, 12, Article ID: 587250. [Google Scholar] [CrossRef] [PubMed]
[40] Wang, N., Yang, H., Li, C., et al. (2017) Using “Swallow-Tail” Sign and Putaminal Hypointensity as Biomarkers to Distinguish Multiple System Atrophy from Idiopathic Parkinson’s Disease: A Susceptibility-Weighted Imaging Study. European Radiology, 27, 3174-3180. [Google Scholar] [CrossRef] [PubMed]
[41] 陈娜, 徐志锋. 磁共振弥散张量成像及磁共振波谱技术对帕金森病诊断价值研究[J]. 功能与分子医学影像学(电子版), 2018, 7(1): 1370-1374.
[42] Wang, G.J., Volkow, N.D., Fowler, J.S., et al. (1995) Comparison of Two PET Radioligands for Imaging Extrastriatal Dopamine Transporters in Human Brain. Life Sciences, 57, 246-249. [Google Scholar] [CrossRef] [PubMed]
[43] Guttman, M., Burkholder, J., Kish, S.J., et al. (1997) [11C]RTI-32 PET Studies of the Dopamine Transporter in Early Dopa-Naive Parkinson’s Disease: Implications for the Symptomatic Threshold. Neurology, 48, 1578-1583. [Google Scholar] [CrossRef] 
[44] Kazumata, K., Dhawan, V., Chaly, T., et al. (1998) Dopamine Transporter Imaging with Fluorine-18-FPCIT and PET. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine, 39, 1521.
[45] Laakso, A., Bergman, J., Haaparanta, M., et al. (1996) [18F]CFT [(18F)WIN 35,428], a Radioligand to Study the Dopamine Transporter with PET: Characterization in Human Subjects. Synapse, 23, 321-327.
[46] Ilgin, N., Zubieta, J., Reich, S.G., et al. (1999) PET Imaging of the Dopamine Transporter in Progressive Supranuclear Palsy and Parkinson’s Disease. Neurology, 52, 1221-1226. [Google Scholar] [CrossRef] 
[47] 崔丽莉, 程刚. PET/CT对帕金森病早期诊断价值的研究[J]. 中国临床医学影像杂志, 2018, 29(6): 435-438.
[48] Duraes, F., Pinto, M. and Sousa, E. (2018) Old Drugs as New Treatments for Neurodegenerative Diseases. Pharmaceuticals (Basel), 11, 44. [Google Scholar] [CrossRef] [PubMed]
[49] 冼文彪, 刘焯霖, 陈玲, 等. [11C]CFT脑多巴胺转运体PET显像对帕金森病诊断和严重程度评估的应用[J]. 中国神经精神疾病杂志, 2014(8): 474-478.
[50] 邓伟胜, 楼云龙, 苏中振. 正电子发射型计算机断层显像在帕金森病患者早期诊断中的应用[J]. 中国实用医药, 2018, 13(7): 3-5.
[51] 倪夏珺, 丁正同, 邬剑军, 等. [11C]-β-CFT脑多巴胺转运体PET显像在帕金森病诊断中的应用[J]. 中国临床神经科学, 2009, 17(4): 371-376.
[52] 杨晖, 沈智辉, 徐白萱. 11C-CFT PET/CT显像鉴别多系统萎缩与帕金森病的价值[J]. 中国医学影像学杂志, 2017, 25(5): 349-353.
[53] 李玲, 吴平, 邬剑军, 等. 多巴胺转运体PET显像对帕金森病和进行性核上性麻痹的鉴别诊断价值研究[J]. 中国临床神经科学, 2018, 26(3): 262-268.
[54] Mishina, M., Ishii, K., Suzuki, M., et al. (2011) Striatal Distribution of Dopamine Transporters and Dopamine D2 Receptors at Different Stages of Parkinson’s Disease. A CFT and RAC PET Study. The Neuroradiology Journal, 24, 235-241. [Google Scholar] [CrossRef] [PubMed]
[55] Liu, L., Wang, Y., Li, B., et al. (2009) Evaluation of Nigrostriatal Damage and Its Change over Weeks in a Rat Model of Parkinson’s Disease: Small Animal Positron Emission Tomography Studies with [11C]β-CFT. Nuclear Medicine and Biology, 36, 941-947. [Google Scholar] [CrossRef] [PubMed]

为你推荐